Loading the company…
Loading the company…
In the last ten years FDA made 4 decisions for Tela Bio (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2026-09-28.
| Family | Decisions on record |
|---|---|
| Hernia repair | 5 |
In 2025, Tela Bio reported engagement with 2,721 surgeons and other clinicians in the states MedaRep covers, worth $1.8M in consulting, speaking, meals and travel for its device products, the most in Indiana ($362K to 61). Royalties are left out.
| OVINE TISSUE MATRIX(OTM) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Tela Bio.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Indiana ($362K, 61 engaged), Florida ($305K, 438 engaged), California ($242K, 201 engaged), Colorado ($215K, 107 engaged), Texas ($170K, 285 engaged).